|
參 考 文 獻 1.Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006 Sep-Oct;56(5):254-81. 2.World_Health_Organization. WHO Fact sheet No. 297: Cancer. In: World Health Organization; 2006. 3.Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 1998 Aug 14;130(1-2):1-7. 4.Smets LA. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs. 1994 Feb;5(1):3-9. 5.Cordell GA, Araujo OE. Capsaicin: identification, nomenclature, and pharmacotherapy. Ann Pharmacother. 1993 Mar;27(3):330-6. 6.Govindarajan VS, Sathyanarayana MN. Capsicum--production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences. Crit Rev Food Sci Nutr. 1991;29(6):435-74 7.Agrawal RC, Wiessler M, Hecker E, Bhide SV. Tumour-promoting effect of chilli extract in BALB/c mice. Int J Cancer. 1986 Nov 15;38(5):689-95.
8.Azizan A, Blevins RD. Mutagenicity and antimutagenicity testing of six chemicals associated with the pungent properties of specific spices as revealed by the Ames Salmonella/microsomal assay. Arch Environ Contam Toxicol. 1995 Feb;28(2):248-58. 9.Toth B, Rogan E, Walker B. Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Res. 1984 May-Jun;4(3):117-9. 10.Mori A, Lehmann S, O''Kelly J, Kumagai T, Desmond JC, Pervan M, et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res. 2006 Mar 15;66(6):3222-9. 11.Sanchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, Diaz-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis. 2007 Nov;12(11):2013-24. 12.Tuoya, Baba N, Shimoishi Y, Murata Y, Tada M, Koseki M, et al. Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells. Life Sci. 2006 Feb 23;78(13):1515-9. Epub 2005 Nov 2.. 13.Lo YC, Yang YC, Wu IC, Kuo FC, Liu CM, Wang HW, et al. Capsaicin-induced cell death in a human gastric adenocarcinoma cell line. World J Gastroenterol. 2005 Oct 28;11(40):6254-7. 14.Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK. Induction of Apoptosis in Tumor Cells by Natural Phenolic Compounds. Asian Pac.J.Cancer.Prev. 2002;3(1):61-67.
15.Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004 Feb 1;64(3):1071-8. 16.Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, et al. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem Biophys Res Commun. 1999 Aug 19;262(1):275-84. 17.Jin Y, Ishihata K, Kajiyama S, Fukusaki E, Kobayashi A, Baba N, et al. Effect of capsaicin and N-docosahexaenoyl-vanillylamide on growth of taxol-tolerant HeLa cells. Japanese Journal of Food Chemistry 2002;9(2):50-53. 18.Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R, et al. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett. 1997 Dec 9;120(2):235-41. 19.Lee YS, Nam DH, Kim JA. Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Lett. 2000 Dec 8;161(1):121-30. 20.Macho A, Calzado MA, Munoz-Blanco J, Gomez-Diaz C, Gajate C, Mollinedo F, et al. Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ. 1999 Feb;6(2):155-65.
21.Morre DJ, Chueh PJ, Morre DM. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1831-5. 22.Morre DJ, Sun E, Geilen C, Wu LY, de Cabo R, Krasagakis K, et al. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer. 1996 Oct;32A(11):1995-2003. 23.Wolvetang EJ, Larm JA, Moutsoulas P, Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 1996 Oct;7(10):1315-25. 24.Kim S, Moon A. Capsaicin-induced apoptosis of H-ras-transformed human breast epithelial cells is Rac-dependent via ROS generation. Arch Pharm Res. 2004 Aug;27(8):845-9. 25.Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta. 2007 Aug;1772(8):937-46. 26.Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007 May;6(5):357-72. 27.Reilly CA, Johansen ME, Lanza DL, Lee J, Lim JO, Yost GS. Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells. J Biochem Mol Toxicol 2005;19(4):266-75. 28.Athanasiou A, Smith PA, Vakilpour S, Kumaran NM, Turner AE, Bagiokou D, et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun. 2007 Mar 2;354(1):50-5. 29.Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 2003 Oct;228(9):995-1003. 30.Statistics of causes of death, 2005. In: Department of Health EYT, editor. Taiwan, R.O.C.: Department of Health, Executive Yuan, Taiwan; 2006. 31.What are the key statistics for breast cancer? In: American Cancer Society; 2006. 32.Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene. 2004 Apr 12;23(16):2746-56. 33.Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002 Dec 27;181-182:471-4. 34.Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995 Jan;146(1):3-15. 35.Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: a new skin for the old ceremony? Biochem Biophys Res Commun. 1999 Dec 29;266(3):699-717. 36.Ferri KF, Kroemer G. Control of apoptotic DNA degradation. Nat Cell Biol. 2000 Apr;2(4):E63-4.
37.Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol. 2001 Nov;3(11):E255-63. 38.Hengartner MO. The biochemistry of apoptosis. Nature. 2000 Oct 12;407(6805):770-6. 39.Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998 Aug 28;281(5381):1312-6. 40.Green D, Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 1998;8(7):267-71. 41.Debatin K. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett. 2000 Mar 15;112-113:41-8. 42.Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, et al. Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis. Breast Cancer Res Treat. 1999 Feb;53(3):263-9. 43.Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol. 2002 Nov;50(5):343-52. Epub 2002 Oct 3. 44.Kim R, Inoue H, Toge T. Bax is an important determinant for radiation sensitivity in esophageal carcinoma cells. Int J Mol Med. 2004 Oct;14(4):697-706. 45.Tanabe K, Kim R, Inoue H, Emi M, Uchida Y, Toge T. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs. Int J Oncol. 2003 Apr;22(4):875-81.
46.Verrier F, Deniaud A, Lebras M, Metivier D, Kroemer G, Mignotte B, et al. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene. 2004 Oct 21;23(49):8049-64. 47.Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie. 2002 Feb-Mar;84(2-3):203-14. 48.Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci. 2002 Dec 15;115(Pt 24):4727-34. 49.Lakhani SA, Masud A, Kuida K, Porter GA, Jr., Booth CJ, Mehal WZ, et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006 Feb 10;311(5762):847-51. 50.Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, et al. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie. 2002 Feb-Mar;84(2-3):215-22. 51.Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene. 2002 Jan 3;21(1):65-77. 52.Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 2004 May;25(5):259-64. 53.Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 2002 Jul 12;297(5579):259-63. 54.Zhang J, Dong M, Li L, Fan Y, Pathre P, Dong J, et al. Endonuclease G is required for early embryogenesis and normal apoptosis in mice. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15782-7. 55.Wu J. Apoptosis and angiogenesis: two promising tumor markers in breast cancer (review). Anticancer Res. 1996 Jul-Aug;16(4B):2233-9. 56.Furth PA, Bowcock AM. Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics. In: Anonymous, editor. Apoptosis and the development of breast cancer. New Jersey: Humana Press; 1999. p. 171-180. 57.Fulda S, Debatin KM. Signaling through death receptors in cancer therapy. Curr Opin Pharmacol. 2004 Aug;4(4):327-32. 58.Waxman DJ, Schwartz PS. Harnessing apoptosis for improved anticancer gene therapy. Cancer Res. 2003 Dec 15;63(24):8563-72. 59.Bykov VJ, Wiman KG. Novel cancer therapy by reactivation of the p53 apoptosis pathway. Ann Med. 2003;35(7):458-65. 60.Norris JS, Hyer ML, Voelkel-Johnson C, Lowe SL, Rubinchik S, Dong JY. The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer. Curr Gene Ther. 2001 May;1(1):123-36. 61.Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene. 2002 Dec 12;21(57):8843-51.
62.Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 2001 Jan 1;61(1):348-54. 63.Yang XH, Edgerton S, Thor AD. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int J Oncol. 2005 Jun;26(6):1675-80. 64.Janicke RU, Ng P, Sprengart ML, Porter AG. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem. 1998 Jun 19;273(25):15540-5. 65.Mathiasen IS, Lademann U, Jaattela M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 1999 Oct 1;59(19):4848-56. 66.Xue LY, Chiu SM, Oleinick NL. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp Cell Res. 2001 Feb 1;263(1):145-55. 67.Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998 Apr 17;273(16):9357-60. 68.Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res. 2006 Jan-Feb;26(1A):227-42. 69.Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World journal of gastroenterology : World J Gastroenterol. 2006 Jan 7;12(1):21-8. 70.Ormerod MG. In: Anonymous, editor. Flow Cytometry: A Practical Approach. New York: Oxford University Press; 1990. p. 69-81. 71.Wu LT, Chu CC, Chung JG, Chen CH, Hsu LS, Liu JK, et al. Effects of tannic acid and its related compounds on food mutagens or hydrogen peroxide-induced DNA strands breaks in human lymphocytes. Mutat Res. 2004 Nov 22;556(1-2):75-82. 72.Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol. 2003 Feb;70(2):84-90. 73.Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol. 1994 Feb;55(2):253-8. 74.Jakubowski W, Bartosz G. 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 2000;24(10):757-60. 75.Sanchez Ferrer A, Santema JS, Hilhorst R, Visser AJ. Fluorescence detection of enzymatically formed hydrogen peroxide in aqueous solution and in reversed micelles. Anal Biochem. 1990 May 15;187(1):129-32. 76.Grierson JP, Petroski RE, O''Connell SM, Geller HM. Calcium homeostasis in dissociated embryonic neurons: a flow cytometric analysis. J Neurophysiol. 1992 Mar;67(3):704-14. 77.Griffiths EJ, Stern MD, Silverman HS. Measurement of mitochondrial calcium in single living cardiomyocytes by selective removal of cytosolic indo 1. Am J Physiol. 1997 Jul;273(1 Pt 1):C37-44. 78.Lopez M, Olive D, Mannoni P. Analysis of cytosolic ionized calcium variation in polymorphonuclear leukocytes using flow cytometry and Indo-1 AM. Cytometry. 1989 Mar;10(2):165-73. 79.Zhou Z, Matlib MA, Bers DM. Cytosolic and mitochondrial Ca2+ signals in patch clamped mammalian ventricular myocytes. J Physiol. 1998 Mar 1;507 ( Pt 2):379-403. 80.Jenssen HL, Redmann K, Mix E. Flow cytometric estimation of transmembrane potential of macrophages--a comparison with microelectrode measurements. Cytometry. 1986 Jul;7(4):339-46. 81.Lee C, Chen LB. Dynamic behavior of endoplasmic reticulum in living cells. Cell. 1988 Jul 1;54(1):37-46. 82.Lee C, Wu SS, Chen LB. Photosensitization by 3,3''-dihexyloxacarbocyanine iodide: specific disruption of microtubules and inactivation of organelle motility. Cancer Res. 1995 May 15;55(10):2063-9. 83.Rottenberg H, Wu S. Mitochondrial dysfunction in lymphocytes from old mice: enhanced activation of the permeability transition. Biochem Biophys Res Commun. 1997 Nov 7;240(1):68-74. 84.Sabnis RW, Deligeorgiev TG, Jachak MN, Dalvi TS. DiOC6(3): a useful dye for staining the endoplasmic reticulum. Biotech Histochem. 1997 Sep;72(5):253-8.
85.Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4. 86.Surh YJ, Lee SS. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci 1995;56(22):1845-55. 87.Olajos EJ, Salem H. Riot control agents: pharmacology, toxicology, biochemistry and chemistry. J Appl Toxicol. 2001 Sep-Oct;21(5):355-91. 88.Surh YJ, Lee RC, Park KK, Mayne ST, Liem A, Miller JA. Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis. 1995 Oct;16(10):2467-71. 89.Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994 Aug 26;78(4):539-42. 90.Friesen C, Fulda S, Debatin KM. Cytotoxic drugs and the CD95 pathway. Leukemia. 1999 Nov;13(11):1854-8. 91.Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 2000 Jul 7;102(1):1-4. 92.Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001 Aug;2(8):589-98. 93.Brown JM, Wouters BG. Apoptosis: mediator or mode of cell killing by anticancer agents? Drug Resist Updat. 2001 Apr;4(2):135-6. 94.Schmitt CA, Lowe SW. Apoptosis is critical for drug response in vivo. Drug Resist Updat. 2001 Apr;4(2):132-4. 95.Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun. 2005 Dec 16;338(2):694-9. 96.Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, et al. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci. 1999 Jan 15;19(2):529-38. 97.Mohamad N, Gutierrez A, Nunez M, Cocca C, Martin G, Cricco G, et al. Mitochondrial apoptotic pathways. Biocell. 2005 Aug;29(2):149-61.
|